Development

Jessica Baseggio is research laboratory analysts at SG Lab Analytics, Stevanato Group.

Chiara Callegari is research laboratory analysts at SG Lab Analytics, Stevanato Group.

Enrico Barichello is SG Alba Platform product manager, Stevanato Group, 

Articles

A coating technology for a staked needle prefillable syringe reduces the potential risks associated with silicone oil as a lubricant.

Considering a Coating Technology as an Alternative to Silicone Oil

In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.

Poseida Therapeutics and Takeda Partner to Develop Non-Viral In-Vivo Gene Therapy Programs

Editor of Pharmaceutical Technology Europe

The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.

Getting a Nose for Vaccines

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

GSK announced that FDA has approved a new indication for Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5.

FDA Approves GSK’s Treatment for Chronic Rhinosinusitis with Nasal Polyps 

In combination with etoposide and either carboplatin or cisplatin, Imfinzi has been approved in the first-line setting of ES-SCLC by China’s National Medical Products Administration.

AstraZeneca’s Extensive-Stage Small Cell Lung Cancer Treatment Approved in China

Vaccine development is inherently challenging; however, in light of the COVID-19 pandemic, innovations have been prioritized, leading to accelerated development processes.

Overcoming Vaccine Development Challenges

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe. 

BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe Manufacturing Capacity 

Feliza Mirasol is the science editor for 

Fill/finish inspection for vaccine vials and syringes must remain GMP-compliant while aiming for fast, efficient methods.

Reconfiguring Fill/Finish Inspection to Meet COVID-19 Vaccine Goals

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

Formulation and Drug Delivery, Parenterals